Medical News |
- Comorbid anxiety problematic for adolescents with bipolar disorder
- Comorbid anxiety problematic for adolescents with bipolar disorder
- Metacognitive training complements antipsychotic therapy
- Weight loss reduces pediatric exercise-induced bronchoconstriction
- Metacognitive training complements antipsychotic therapy
- Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy
- DNA methylation signature marks recurrence in early stage lung cancer
- FDG-PET parameter predicts locally advanced lung cancer survival
- Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy
- DNA methylation signature marks recurrence in early stage lung cancer
- FDG-PET parameter predicts locally advanced lung cancer survival
| Comorbid anxiety problematic for adolescents with bipolar disorder Posted: 31 Oct 2013 05:00 PM PDT Anxiety disorders are common in children and adolescents with bipolar disorder and adversely affect their outcomes, suggest study findings. |
| Comorbid anxiety problematic for adolescents with bipolar disorder Posted: 31 Oct 2013 05:00 PM PDT Anxiety disorders are common in children and adolescents with bipolar disorder and adversely affect their outcomes, suggest study findings. |
| Metacognitive training complements antipsychotic therapy Posted: 31 Oct 2013 05:00 PM PDT Metacognitive training may benefit patients with schizophrenia who only partially respond to antipsychotic treatment, study findings show. |
| Weight loss reduces pediatric exercise-induced bronchoconstriction Posted: 31 Oct 2013 05:00 PM PDT A study has found that weight loss in overweight and obese children with exercise-induced bronchoconstriction leads to a significant reduction in symptom severity and improved quality of life. |
| Metacognitive training complements antipsychotic therapy Posted: 31 Oct 2013 05:00 PM PDT Metacognitive training may benefit patients with schizophrenia who only partially respond to antipsychotic treatment, study findings show. |
| Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy Posted: 30 Oct 2013 05:00 PM PDT Two targeted anticancer drugs used together after first-line chemotherapy for advanced stage non-small-cell lung cancer improve progression-free survival, the results of a large, prospective study show. |
| DNA methylation signature marks recurrence in early stage lung cancer Posted: 30 Oct 2013 05:00 PM PDT An international research team has identified a DNA methylation signature that identifies patients with stage I non-small-cell lung cancer who are at high risk for relapse. |
| FDG-PET parameter predicts locally advanced lung cancer survival Posted: 30 Oct 2013 05:00 PM PDT High post-treatment concentrations of a radioactive imaging marker are predictive of worse overall survival from inoperable, locally advanced non-small-cell lung cancer, prospective study findings suggest. |
| Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy Posted: 30 Oct 2013 05:00 PM PDT Two targeted anticancer drugs used together after first-line chemotherapy for advanced stage non-small-cell lung cancer improve progression-free survival, the results of a large, prospective study show. |
| DNA methylation signature marks recurrence in early stage lung cancer Posted: 30 Oct 2013 05:00 PM PDT An international research team has identified a DNA methylation signature that identifies patients with stage I non-small-cell lung cancer who are at high risk for relapse. |
| FDG-PET parameter predicts locally advanced lung cancer survival Posted: 30 Oct 2013 05:00 PM PDT High post-treatment concentrations of a radioactive imaging marker are predictive of worse overall survival from inoperable, locally advanced non-small-cell lung cancer, prospective study findings suggest. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |